Delivery Order SPE2DB20D1004-SPE2DB25FNGPF
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product used for the treatment of ocular conditions. The contract has a ceiling value of $3,432.36 and a completion date of January 13, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, with a ceiling value of $2,063.13 and a performance period through March 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% Eye Drops in 1.7 ml containers, with a ceiling value of $3,194.72 and an ultimate completion date of April 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% Eye Drops in 1.7 mL vials, with a ceiling value of $2,417.25 and a completion date of December 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Bromfenac Sodium 0.09% eye drops. The contract is valued at $3,011.19 and has a firm fixed price pricing type. The ultimate completion date for this order is February 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Bromfenac Sodium 0.09% Eye Drops 1.7 mL. The contract has a firm-fixed price and a ceiling value of $1,860.93. It was awarded on August 7, 2024, with an ultimate completion date of August 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product, with a ceiling value of $2,695.47 and a period of performance ending on November 15, 2024. The contract is not designated as a set-aside and represents an individual delivery order issued under a larger Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
This $5,687.78 delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of Bromfenac Sodium 0.09% eye drops. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. This award is associated with a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,472.28, is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...